Disappointing decision for AstaREAL from EFSA panel

摘要

EFSA Novel Food Ingredient (NFI) Opinion on AstaREAL~®: Unexpected and disappointed, but only a speed bump on the road for natural algal astaxanthin appearing in healthy functional food products. The EFSA panel on Dietetic Products, Nutrition and Allergies (NDA) has published a scientific opinion on the proposed use of 4 mg algal astaxanthin in dairy products and fruit drinks. The panel concluded that the safety of algal astaxanthin at the proposed use and dosage has not been established. Note that this opinion does not affect our ability to market dietary supplements, it only delays our entry into a new market area. This decision comes unexpectedly when there is a wealth of safety data and historical use of natural algal astaxanthin in Europe and the rest of the world. The EFSA report on AstaREAL~® was based on a very recent scientific opinion by the panel on Additives and Products or Substances used in Animal Feed (FEEDAP) that evaluated safety and efficacy of synthetic astaxanthin formulation as feed additives for fish.